Ibex LTD Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
American Century Investment Management, Inc., along with its parent companies, has reported beneficial ownership of 3.8% of IBEX Limited's common stock.
NASDAQ
American Century Investment Management has filed a Schedule 13G reporting a 5.1% beneficial ownership stake in IBEX Limited.
NASDAQ
American Century Capital Portfolios, Inc., American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research have filed an Amendment No. 5 to their Schedule 13G, reporting beneficial ownership of 4.4% of IBEX Limited's Common Stock.
NASDAQ
JPMorgan Chase & Co. has filed an amended Schedule 13G, disclosing a 2.9% beneficial ownership stake in IBEX LIMITED as of April 30, 2025.
NASDAQ
JPMorgan Chase & Co. has reported a 5.1% beneficial ownership stake in IBEX LIMITED, primarily through its banking and investment management subsidiaries.
NASDAQ
American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research have jointly reported a 5.6% beneficial ownership stake in IBEX Limited as of December 31, 2024.